These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38029571)

  • 21. Cereblon target validation using a covalent inhibitor of neosubstrate recruitment.
    Dann GP; Liu H; Nowak RP; Jones LH
    Methods Enzymol; 2023; 681():155-167. PubMed ID: 36764755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Building ubiquitination machineries: E3 ligase multi-subunit assembly and substrate targeting by PROTACs and molecular glues.
    Ramachandran S; Ciulli A
    Curr Opin Struct Biol; 2021 Apr; 67():110-119. PubMed ID: 33271439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advancements in the discovery of cereblon-based protease-targeted chimeras with potential for therapeutic intervention.
    Singh H; Agrawal DK
    Future Med Chem; 2022 Oct; 14(19):1403-1416. PubMed ID: 36047364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective Degradation of GSPT1 by Cereblon Modulators Identified via a Focused Combinatorial Library.
    Powell CE; Du G; Che J; He Z; Donovan KA; Yue H; Wang ES; Nowak RP; Zhang T; Fischer ES; Gray NS
    ACS Chem Biol; 2020 Oct; 15(10):2722-2730. PubMed ID: 32865967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. USP15 antagonizes CRL4
    Nguyen TV
    Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34583995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advancing targeted protein degrader discovery by measuring cereblon engagement in cells.
    Zerfas BL; Huerta F; Liu H; Du G; Gray NS; Jones LH; Nowak RP
    Methods Enzymol; 2023; 681():169-188. PubMed ID: 36764756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An E3 ligase guide to the galaxy of small-molecule-induced protein degradation.
    Jevtić P; Haakonsen DL; Rapé M
    Cell Chem Biol; 2021 Jul; 28(7):1000-1013. PubMed ID: 33891901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology.
    Ito T; Yamaguchi Y; Handa H
    Cell Chem Biol; 2021 Jul; 28(7):987-999. PubMed ID: 34033753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Translation of Targeted Protein Degraders.
    Kong NR; Jones LH
    Clin Pharmacol Ther; 2023 Sep; 114(3):558-568. PubMed ID: 37399310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy.
    Liu TT; Yang H; Zhuo FF; Yang Z; Zhao MM; Guo Q; Liu Y; Liu D; Zeng KW; Tu PF
    EBioMedicine; 2022 Dec; 86():104353. PubMed ID: 36375317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein Degradation via CRL4
    Hansen JD; Condroski K; Correa M; Muller G; Man HW; Ruchelman A; Zhang W; Vocanson F; Crea T; Liu W; Lu G; Baculi F; LeBrun L; Mahmoudi A; Carmel G; Hickman M; Lu CC
    J Med Chem; 2018 Jan; 61(2):492-503. PubMed ID: 28358507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cereblon: promise and challenges for combating human diseases.
    Kim HK; Seol JE; Ahn SW; Jeon S; Park CS; Han J
    Pflugers Arch; 2021 Nov; 473(11):1695-1711. PubMed ID: 34553266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs.
    Lindner S; Steinebach C; Kehm H; Mangold M; Gütschow M; Krönke J
    J Vis Exp; 2019 May; (147):. PubMed ID: 31157769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Driving E3 Ligase Substrate Specificity for Targeted Protein Degradation: Lessons from Nature and the Laboratory.
    Cowan AD; Ciulli A
    Annu Rev Biochem; 2022 Jun; 91():295-319. PubMed ID: 35320687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of host-directed and virus-specific antivirals using targeted protein degradation promoted by small molecules and viral RNA mimics.
    Zhao N; Ho JSY; Meng F; Zheng S; Kurland AP; Tian L; Rea-Moreno M; Song X; Seo JS; Kaniskan HÜ; Te Velthuis AJW; Tortorella D; Chen YW; Johnson JR; Jin J; Marazzi I
    Cell Host Microbe; 2023 Jul; 31(7):1154-1169.e10. PubMed ID: 37339625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The emerging role for Cullin 4 family of E3 ligases in tumorigenesis.
    Cheng J; Guo J; North BJ; Tao K; Zhou P; Wei W
    Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):138-159. PubMed ID: 30602127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2.
    Lian Q; Gao Y; Li Q; He X; Jiang X; Pu Z; Xu G
    Protein J; 2020 Oct; 39(5):411-421. PubMed ID: 33009960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteolysis-targeting chimeras (PROTACs) in cancer therapy.
    Li X; Pu W; Zheng Q; Ai M; Chen S; Peng Y
    Mol Cancer; 2022 Apr; 21(1):99. PubMed ID: 35410300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs.
    Bai N; Riching KM; Makaju A; Wu H; Acker TM; Ou SC; Zhang Y; Shen X; Bulloch DN; Rui H; Gibson BW; Daniels DL; Urh M; Rock BM; Humphreys SC
    J Biol Chem; 2022 Apr; 298(4):101653. PubMed ID: 35101445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cereblon modulators: Low molecular weight inducers of protein degradation.
    Chamberlain PP; Cathers BE
    Drug Discov Today Technol; 2019 Apr; 31():29-34. PubMed ID: 31200856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.